Management of acute-on-chronic liver failure: an algorithmic approach
- PMID:30116993
- DOI: 10.1007/s12072-018-9887-5
Management of acute-on-chronic liver failure: an algorithmic approach
Abstract
Acute-on-chronic liver failure (ACLF) is a distinct syndrome of liver failure in a patient with chronic liver disease presenting with jaundice, coagulopathy and ascites and/or hepatic encephalopathy, developing following an acute hepatic insult and associated with high 28-day mortality. The definition though lacks global consensus, excludes patients with known distinct entities such as acute liver failure and those with end-stage liver disease. The initial Systemic Inflammatory Response Syndrome (SIRS) because of cytokine storm in relation to acute insult and/or subsequent development of sepsis due to immunoparalysis leads to extrahepatic organ failure. These cascades of events progress through a 'Golden Window' period of about 7 days, subsequent to which majority of the patients develop complications, such as sepsis and extrahepatic organ failure. Prevention of sepsis, support of organs and management of organ failure (commonly hepatic, renal, cerebral, coagulation) and early referral for transplant is crucial. The APASL ACLF research consortium (AARC) liver failure score is a dynamic prognostic model for management decisions and is superior to existing models. Aggressive multidisciplinary approach can lead to a transplant-free survival in nearly half of the cases. The present review provides an algorithmic approach to management of organ failure, sepsis prevention, use of dynamic prognostic models for management decision and is aimed to improve the skills for managing and improving the outcomes of such critically ill patients.
Keywords: ACLF; APASL; Liver failure; Organ failure.
Similar articles
- Acute-on-chronic Liver Failure.Sarin SK, Choudhury A.Sarin SK, et al.Curr Gastroenterol Rep. 2016 Dec;18(12):61. doi: 10.1007/s11894-016-0535-8.Curr Gastroenterol Rep. 2016.PMID:27747458Review.
- Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update.Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, Saigal S, Saraf N, Soin AS, Devarbhavi H, Kim DJ, Dhiman RK, Duseja A, Taneja S, Eapen CE, Goel A, Ning Q, Chen T, Ma K, Duan Z, Yu C, Treeprasertsuk S, Hamid SS, Butt AS, Jafri W, Shukla A, Saraswat V, Tan SS, Sood A, Midha V, Goyal O, Ghazinyan H, Arora A, Hu J, Sahu M, Rao PN, Lee GH, Lim SG, Lesmana LA, Lesmana CR, Shah S, Prasad VGM, Payawal DA, Abbas Z, Dokmeci AK, Sollano JD, Carpio G, Shresta A, Lau GK, Fazal Karim M, Shiha G, Gani R, Kalista KF, Yuen MF, Alam S, Khanna R, Sood V, Lal BB, Pamecha V, Jindal A, Rajan V, Arora V, Yokosuka O, Niriella MA, Li H, Qi X, Tanaka A, Mochida S, Chaudhuri DR, Gane E, Win KM, Chen WT, Rela M, Kapoor D, Rastogi A, Kale P, Rastogi A, Sharma CB, Bajpai M, Singh V, Premkumar M, Maharashi S, Olithselvan A, Philips CA, Srivastava A, Yachha SK, Wani ZA, Thapa BR, Saraya A, Shalimar, Kumar A, Wadhawan M, Gupta S, Madan K, Sakhuja P, Vij V, Sharma BC, Garg H, Garg V, Kalal C, Anand L, Vyas T, Mathur RP, Kumar G, Jain P, Pasupuleti SSR, Chawla YK, Chowdhury A, Alam S, Song DS, Yang JM, Yoon EL; APASL ACLF Research Consortium (AARC) for APASL ACLF working Party..Sarin SK, et al.Hepatol Int. 2019 Jul;13(4):353-390. doi: 10.1007/s12072-019-09946-3. Epub 2019 Jun 6.Hepatol Int. 2019.PMID:31172417Free PMC article.
- Systemic inflammatory response syndrome in acute-on-chronic liver failure: Relevance of 'golden window': A prospective study.Choudhury A, Kumar M, Sharma BC, Maiwall R, Pamecha V, Moreau R, Chawla YK, Duseja A, Mahtab M, Rahman S, Hamid SS, Butt AS, Jafri W, Tan SS, Devarbhavi H, Amarapurkar D, Ning Q, Eapen CE, Goel A, Kim DJ, Ghazinyan H, Shiha G, Lee GH, Abbas Z, Payawal DA, Dokmeci AK, Yuen MF, Lesmana LA, Sood A, Chan A, Lau GK, Jia JD, Duan Z, Yu C, Yokosuka O, Jain P, Bhadoria AS, Kumar G, Sarin SK; APASL ACLF working party.Choudhury A, et al.J Gastroenterol Hepatol. 2017 Dec;32(12):1989-1997. doi: 10.1111/jgh.13799.J Gastroenterol Hepatol. 2017.PMID:28374414
- Acute-on-chronic liver failure: Terminology, mechanisms and management.Br VK, Sarin SK.Br VK, et al.Clin Mol Hepatol. 2023 Jul;29(3):670-689. doi: 10.3350/cmh.2022.0103. Epub 2023 Mar 20.Clin Mol Hepatol. 2023.PMID:36938601Free PMC article.Review.
- How to identify the need for liver transplantation in pediatric acute-on-chronic liver failure?Lal BB, Sood V, Khanna R, Alam S.Lal BB, et al.Hepatol Int. 2018 Nov;12(6):552-559. doi: 10.1007/s12072-018-9901-y. Epub 2018 Oct 19.Hepatol Int. 2018.PMID:30341639
Cited by
- PROGNOSTIC FACTORS OF LIVER TRANSPLANTATION FOR ACUTE-ON-CHRONIC LIVER FAILURE.Cronst J, Prediger L, Pinto MA, Ferraz J, Mattos AZ, Alvares-DA-Silva MR, Kruel CRP, Chedid MF.Cronst J, et al.Arq Bras Cir Dig. 2023 Dec 8;36:e1779. doi: 10.1590/0102-672020230061e1779. eCollection 2023.Arq Bras Cir Dig. 2023.PMID:38088725Free PMC article.
- Comparing Eight Prognostic Scores in Predicting Mortality of Patients with Acute-On-Chronic Liver Failure Who Were Admitted to an ICU: A Single-Center Experience.Chen BH, Tseng HJ, Chen WT, Chen PC, Ho YP, Huang CH, Lin CY.Chen BH, et al.J Clin Med. 2020 May 20;9(5):1540. doi: 10.3390/jcm9051540.J Clin Med. 2020.PMID:32443729Free PMC article.
- Advances in management of end stage liver disease in children.Aneja A, Scott E, Kohli R.Aneja A, et al.Med J Armed Forces India. 2021 Apr;77(2):129-137. doi: 10.1016/j.mjafi.2021.03.001. Epub 2021 Mar 25.Med J Armed Forces India. 2021.PMID:33867627Free PMC article.Review.
- Artificial intelligence-based evaluation of prognosis in cirrhosis.Zhai Y, Hai D, Zeng L, Lin C, Tan X, Mo Z, Tao Q, Li W, Xu X, Zhao Q, Shuai J, Pan J.Zhai Y, et al.J Transl Med. 2024 Oct 14;22(1):933. doi: 10.1186/s12967-024-05726-2.J Transl Med. 2024.PMID:39402630Free PMC article.Review.
- Network Pharmacology Approach to Explore the Potential Mechanisms of Jieduan-Niwan Formula Treating Acute-on-Chronic Liver Failure.Liang J, Wu M, Bai C, Ma C, Fang P, Hou W, Wei X, Zhang Q, Du Y.Liang J, et al.Evid Based Complement Alternat Med. 2020 Dec 30;2020:1041307. doi: 10.1155/2020/1041307. eCollection 2020.Evid Based Complement Alternat Med. 2020.PMID:33456481Free PMC article.
References
Publication types
MeSH terms
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources